Neuroendocrine Cancer

>

CURE’s neuroendocrine cancer page features the latest cancer news and updates on neuroendocrine cancer Through articles, videos, podcasts, and more, CURE brings readers the insights of experts, cancer survivors, patients, and advocates to ensure everyone is up to date in neuroendocrine cancer.

Latest News

FDA sign.
Dive Into March 2025 FDA Approvals Across Cancer Subtypes

April 1st 2025

Here is a roundup of March 2025 U.S. FDA approvals across cancer subtypes, including prostate, bladder and gastrointestinal cancers.

"FDA" text.
FDA Approves Cabometyx for Some Neuroendocrine Tumors

March 26th 2025

Illustration of cells.
177Lu-edotreotide May Delay Progression in Neuroendocrine Tumor Subset

March 7th 2025

Image of GI cancer.
ITM-11 Meets Phase 3 Trial Primary End Point of PFS in GEP-NETs

February 2nd 2025

Illustration of cells.
FDA Accepts sNDA for Welireg in Advanced Pheochromocytoma and Paraganglioma

January 29th 2025

Video Interviews
Podcasts
Cancer Survivor Tara Rolle holding a copy of her book, "The White Noise of Survivorship and Other Unsolicited Lessons I Learned From Cancer"

More News